We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

37 hedge funds and large institutions have $17.9M invested in Fibrocell Science Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less funds holding

Funds holding: 44 → 37 (-7)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

43% less capital invested

Capital invested by funds: $31.4M → $17.9M (-$13.5M)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
37
Holders Change
-7
Holders Change %
-15.91%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
8
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$51.5K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7K
3
TRCT
Tower Research Capital (TRC)
New York
+$12.9K
4
VKH
Virtu KCG Holdings
New York
+$10.4K
5
UBS Group
UBS Group
Switzerland
+$5.93K

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$1.43M
2
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$398K
3
OAM
Oxford Asset Management
United Kingdom
-$167K
4
PP
Paloma Partners
Connecticut
-$111K
5
CS
Credit Suisse
Switzerland
-$101K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$12M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.88M – – –
MP
3
MSD Partners
New York
$1.5M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$945K +$14.7K +994 +1%
QF
5
QVT Financial
New York
$335K -$1.43M -96,532 -76%
Cambridge Investment Research Advisors
6
Cambridge Investment Research Advisors
Iowa
$181K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$129K +$119 +8 +0.1%
HVC
8
Healthcare Value Capital
New Jersey
$106K – – –
OAM
9
Oxford Asset Management
United Kingdom
$104K -$167K -11,263 -54%
Goldman Sachs
10
Goldman Sachs
New York
$102K +$148 +10 +0.1%
BIT
11
BlackRock Institutional Trust
California
$98K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$79K – – –
SCA
13
STALEY CAPITAL ADVISERS
Pennsylvania
$71K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$69K -$16K -1,076 -14%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$61K -$97.3K -6,558 -54%
BFA
16
BlackRock Fund Advisors
California
$44K +$44 +3 +0.1%
Renaissance Technologies
17
Renaissance Technologies
New York
$38K +$51.5K +3,473 New
Morgan Stanley
18
Morgan Stanley
New York
$36K -$19.5K -1,312 -28%
FSA
19
Franklin Street Advisors
North Carolina
$36K – – –
SIP
20
Stoneridge Investment Partners
Pennsylvania
$31K -$208 -14 -0.5%
Northern Trust
21
Northern Trust
Illinois
$27K -$2.02K -136 -5%
MLM
22
Mount Lucas Management
Pennsylvania
$18K +$4.45K +300 +22%
Creative Planning
23
Creative Planning
Kansas
$16K – – –
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$15K – – –
TRCT
25
Tower Research Capital (TRC)
New York
$10K +$12.9K +873 +909%
1
2

FCSC Hedge Fund Activity: Q3 2016 in Review

37 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2016, worth a combined $17.9M — down 43% from $31.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FCSC and 4 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $51.5K. The largest seller was QVT Financial, cutting an estimated $1.43M.

  • 37 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2016, down from 44 in Q2 2016.
  • Funds reported $17.9M of Fibrocell Science Inc. stock for Q3 2016, down 43% quarter-over-quarter.
  • 4 funds opened new Fibrocell Science Inc. positions in Q3 2016 and 11 closed out, a net change of -7 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $51.5K added.
  • The largest Fibrocell Science Inc. seller in Q3 2016 was QVT Financial, an estimated $1.43M sold.

Based on aggregated 13F filings for Q3 2016.